Análisis Argos
SBRA
SBRACara1 señal de riesgo
Sabra Health Care REIT, Inc. · Real Estate
US$ 20.16
precio al 2026-07-04
Valor justo Argos*
US$ 15–17
vs. su valor justo
20% por encima
Score Argos
49/100
LA RESPUESTA
El mercado le pide crezca 9.4% al año — más de lo que ha demostrado (1.9%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Cotiza 16% por debajo de su valor justo.
Las ganancias crecieron 23% el último año.
Reparte dividendo sostenible (5.95%).
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
!Altman Z'' en zona roja (0.06)
VALOR2/6FUTURO4/6PASADO3/6SALUD1/6DIVIDENDO5/6
El Iris de calidad
VALOR2/6FUTURO4/6PASADO3/6SALUD1/6DIVIDENDO5/6
ValorCerca de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial aceptable
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos49de 100Cara
Ingresos10%
US$ 0.8 B
Margen operativo7%
34.1%
Flujo de caja libre13%
US$ 0.4 B
Deuda neta
US$ 2.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 5.1B
P/E32.7x
EV/EBITDA16.8x
FCF yield6.9%
ROIC4.9%
Margen operativo34.1%
Crecim. ingresos+10.2%/año
Piotroski F6/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

fool.com · 15 jun
Community Healthcare Trust vs. Sabra Health Care REIT: Which Real Estate Stock Is a Better Buy in 2026?
Community Healthcare Trust focuses on high-yield outpatient medical facilities in diverse geographical markets. Sabra Health Care REIT operates a massive portfolio centered on skilled nursing and senior housing across North America.
zacks.com · 8 jun
SBRA vs. CUBE: Which Stock Is the Better Value Option?
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Sabra Healthcare (SBRA) or CubeSmart (CUBE). But which of these two stocks offers value investors a better bang for their buck right now?
benzinga.com · 8 jun
AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades'
On CNBC's “Halftime Report Final Trades,” Capital Wealth's Kevin Simpson named The Coca-Cola Company (NYSE:KO) as his final trade.
businesswire.com · 28 may
Sabra Health Care REIT, Inc., Issues Business Update and will Participate in Nareit's REITweek 2026 Investor Conference
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #NAREIT--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the company's website. In addition, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2026 In.
seekingalpha.com · 28 may
U.S. REIT At-The-Market Activity Dips In Q1 2026
Thirty-three US REITs utilized their at-the-market (ATM) offering programs during the recent quarter, raising $4.15 billion in aggregate proceeds. Healthcare REIT Welltower Inc. raised the most capital during the first quarter, selling nearly 7.7 million shares of common stock through its ATM program for $1.56 billion in gross proceeds. In the aggregate, healthcare REITs raised $2.67 billion through their ATM programs during the first quarter, the most of any property sector. The data center REIT sector was next with $875.0 million.
zacks.com · 19 may
FVR vs. SBRA: Which Stock Is the Better Value Option?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both FrontView REIT, Inc. (FVR) and Sabra Healthcare (SBRA). But which of these two stocks is more attractive to value investors?
seekingalpha.com · 17 may
Sabra Health Care REIT A Buy, As Q1 Results Show Portfolio Growth
Sabra Health Care REIT is rated a buy, reflecting portfolio growth, reasonable valuation, and robust geographic diversification. SBRA demonstrates strong revenue and NOI growth but faces declining EBITDA margins and flat long-term dividend growth, tempering its income appeal. The REIT maintains an investment-grade balance sheet, modest debt-to-equity, low operator concentration, and adequate AFFO dividend coverage with a 5.6% yield.
seekingalpha.com · 8 may
Sabra Health Care REIT: A 6% Yield Backed By Powerful Demographic Tailwinds
Sabra Health Care REIT is a 'Buy' with a near 6% yield and 13x forward P/FFO, supported by favorable demographics and industry supply constraints. SBRA's Q1 2026 normalized FFO grew 9% YoY, driven by 14.4% same-store SHOP NOI growth and robust occupancy gains. Management is aggressively deploying capital into SHOP-focused acquisitions at 8% initial cash yields, with a strong pipeline and mostly fixed operating expenses enabling positive operating leverage.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.